Contrast in the efficacy of hDAF mouse hearts between ex vivo perfusion and transplantation into primates

Xenotransplantation

Volumn 8, Issue 4, 2001, Pages 284-291

  Verbakel, Caroline A E ^a   De Bruin, Ron W F ^a   Bonthuis, Fred ^a   Jonker, Margreet ^b   Dekker, Sylvia ^a   Marquet, Richard L ^a   Ijzermans, Jan N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

hDAF or CD55; Human blood; Human serum; Leukocytes; Mouse heart to monkey xenotransplantation

Indexed keywords

COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C9; DECAY ACCELERATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART PERFUSION; HEART TRANSPLANTATION; HUMAN; MACACA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SERUM; SURVIVAL TIME; TRANSGENIC ANIMAL; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

EID: 0034752584     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2001.00132.x     Document Type: Article

References (19)

1. Human CD59 expressed in transgenic mouse hearts inhibits the activation of complement
2. Activation of the alternative pathway of complement in hyperacute xenograft rejection of rabbit hearts by human blood
3. Ex vivo perfusion of mouse hearts expressing the human complement regulatory protein CD59
4. Immunobiology of delayed xenograft rejection
5. Expression and function of human CD59 and human CD55 in transgenic mice
6. Transgenic expression of a CD46 (membrane cofactor protein) mini-gene: Studies of xenotransplantation and measles virus infection
7. Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attack
8. Decay-accelerating factor transgenic mouse hearts are protected from human complement-mediated attack
9. Combination ofdecay-accelerating factor expression and alpha 1, 3-galactosyltransferase knockout affords added protection from human complement-mediated injury
10. In vivo evaluation of human membrane cofactor protein in transgenic mice
11. Human CD46 but not CD59 in transgenic mice protects against hyperacute rejection evoked by ex vivo perfusion with human serum
12. Relative roles of hCD46 and hCD55 in the regulation of hyper-acute rejection
13. A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection
14. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates
15. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage
16. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice
17. High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection
18. Humoral responses to pig-to-baboon cardiac transplantation: Implications for the pathogenesis and treatment of acute vascular rejection and for accommodation
19. Neutrophil adhesion to xenogeneic endothelium via iC3b